• Find People
  • Campus Map
  • PiratePort
  • A-Z
    • About
    • Submit
    • Browse
    • Login
    View Item 
    •   ScholarShip Home
    • Division of Health Sciences
    • College of Allied Health Sciences
    • BioMedCentral
    • View Item
    •   ScholarShip Home
    • Division of Health Sciences
    • College of Allied Health Sciences
    • BioMedCentral
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of The ScholarShipCommunities & CollectionsDateAuthorsTitlesSubjectsTypeDate SubmittedThis CollectionDateAuthorsTitlesSubjectsTypeDate Submitted

    My Account

    Login

    Statistics

    View Google Analytics Statistics

    Impact of pulmonary exposure to gold core silver nanoparticles of different size and capping agents on cardiovascular injury

    Thumbnail
    View/ Open
    12989_2016_159_MOESM1_ESM.docx (27.44Kb)
    12989_2016_Article_159.pdf (3.283Mb)

    Show full item record
    
    Author
    Holland, Nathan A.; Thompson, Leslie C.; Vidanapathirana, Achini K.; Urankar, Rahkee N.; Lust, Robert M.; Fennell, Timothy R.; Wingard, Christopher J.
    Abstract
    Background:The uses of engineered nanomaterials have expanded in biomedical technology and consumer manufacturing. Furthermore, pulmonary exposure to various engineered nanomaterials has, likewise, demonstrated the ability to exacerbate cardiac ischemia reperfusion (I/R) injury. However, the influence of particle size or capping agent remains unclear. In an effort to address these influences we explored response to 2 different size gold core nanosilver particles (AgNP) with two different capping agents at 2 different time points. We hypothesized that a pulmonary exposure to AgNP induces cardiovascular toxicity influenced by inflammation and vascular dysfunction resulting in expansion of cardiac I/R Injury that is sensitive to particle size and the capping agent. Methods: Male Sprague–Dawley rats were exposed to 200 μg of 20 or 110 nm polyvinylprryolidone (PVP) or citrate capped AgNP. One and 7 days following intratracheal instillation serum was analyzed for concentrations of selected cytokines; cardiac I/R injury and isolated coronary artery and aorta segment were assessed for constrictor responses and endothelial dependent relaxation and endothelial independent nitric oxide dependent relaxation. Results: AgNP instillation resulted in modest increase in selected serum cytokines with elevations in IL-2, IL-18, and IL-6. Instillation resulted in a derangement of vascular responses to constrictors serotonin or phenylephrine, as well as endothelial dependent relaxations with acetylcholine or endothelial independent relaxations by sodium nitroprusside in a capping and size dependent manner. Exposure to both 20 and 110 nm AgNP resulted in exacerbation cardiac I/R injury 1 day following IT instillation independent of capping agent with 20 nm AgNP inducing marginally greater injury. Seven days following IT instillation the expansion of I/R injury persisted but the greatest injury was associated with exposure to 110 nm PVP capped AgNP resulted in nearly a two-fold larger infarct size compared to naïve. Conclusions: Exposure to AgNP may result in vascular dysfunction, a potentially maladaptive sensitization of the immune system to respond to a secondary insult (e.g., cardiac I/R) which may drive expansion of I/R injury at 1 and 7 days following IT instillation where the extent of injury could be correlated with capping agents and AgNP size.
    URI
    http://dx.doi.org/10.1186/s12989-016-0159-z
    http://hdl.handle.net/10342/5874
    Subject
     Pulmonary instillation; Myocardial infarction; Coronary artery; Aorta; Serum cytokines; Nanotoxicology 
    Date
    2016-08-24
    Citation:
    APA:
    Holland, Nathan A., & Thompson, Leslie C., & Vidanapathirana, Achini K., & Urankar, Rahkee N., & Lust, Robert M., & Fennell, Timothy R., & Wingard, Christopher J.. (August 2016). Impact of pulmonary exposure to gold core silver nanoparticles of different size and capping agents on cardiovascular injury. Particle and Fibre Toxicology, (13:1), p.48. Retrieved from http://dx.doi.org/10.1186/s12989-016-0159-zhttp://hdl.handle.net/10342/5874

    Display/Hide MLA, Chicago and APA citation formats.

    MLA:
    Holland, Nathan A., and Thompson, Leslie C., and Vidanapathirana, Achini K., and Urankar, Rahkee N., and Lust, Robert M., and Fennell, Timothy R., and Wingard, Christopher J.. "Impact of pulmonary exposure to gold core silver nanoparticles of different size and capping agents on cardiovascular injury". Particle and Fibre Toxicology. 13:1. (48.), August 2016. July 07, 2022. http://dx.doi.org/10.1186/s12989-016-0159-zhttp://hdl.handle.net/10342/5874.
    Chicago:
    Holland, Nathan A. and Thompson, Leslie C. and Vidanapathirana, Achini K. and Urankar, Rahkee N. and Lust, Robert M. and Fennell, Timothy R. and Wingard, Christopher J., "Impact of pulmonary exposure to gold core silver nanoparticles of different size and capping agents on cardiovascular injury," Particle and Fibre Toxicology 13, no. 1 (August 2016), http://dx.doi.org/10.1186/s12989-016-0159-zhttp://hdl.handle.net/10342/5874 (accessed July 07, 2022).
    AMA:
    Holland, Nathan A., Thompson, Leslie C., Vidanapathirana, Achini K., Urankar, Rahkee N., Lust, Robert M., Fennell, Timothy R., Wingard, Christopher J.. Impact of pulmonary exposure to gold core silver nanoparticles of different size and capping agents on cardiovascular injury. Particle and Fibre Toxicology. August 2016; 13(1) 48. http://dx.doi.org/10.1186/s12989-016-0159-zhttp://hdl.handle.net/10342/5874. Accessed July 07, 2022.
    Collections
    • BioMedCentral
    • Physiology

    xmlui.ArtifactBrowser.ItemViewer.elsevier_entitlement

    East Carolina University has created ScholarShip, a digital archive for the scholarly output of the ECU community.

    • About
    • Contact Us
    • Send Feedback